Filing Details
- Accession Number:
- 0000899243-21-009514
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 18:57:58
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-03 18:57:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1695496 | Thomas Brida | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-03-01 | 200 | $41.50 | 207,676 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-01 | 1,481 | $43.35 | 206,195 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-01 | 3,319 | $43.96 | 202,876 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- These sales of common stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2020.
- Represents a weighted average sale price. Actual sale prices ranged from $41.37 to $41.63 per share.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Includes an aggregate of 140,300 shares of common stock issuable pursuant to restricted stock units that have not vested.
- Represents a weighted average sale price. Actual sale prices ranged from $42.65 to $43.64 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $43.65 to $44.44 per share.